The largest database of trusted experimental protocols

2 protocols using anti tgf β 1 2 3 1d11

1

Isolation and Co-culture of Murine Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+CD25- or CD4+ T cells were isolated after mechanical disruption of murine spleens by using the CD4+CD25+ regulatory T cell isolation kit (Miltenyi Biotec) or CD4+ BD IMag beads, respectively, via manufacturer’s instructions. B cells were isolated from murine spleens after mechanical disruption by enriching for CD19+ B cells labeling with CD19+ magnetic beads and processing with MACs columns (Miltenyi Biotec). To isolate DCs, spleens were treated with collagenase and processed using a spleen dissociation kit (Miltenyi Biotec) and subsequently labeled with CD11c+ magnetic beads (Miltenyi Biotec). DCs or B cells were pulsed with 1 or 2 μg/ml of CBirTox for 1–2 hours, respectively, at 37°C. After washing with PBS, DCs and B cells were cultured with CD4+CD25- or CD4+ CBir1 Tg T cells at a ratio of 1:10 or 2:1, respectively with or without the addition of anti-TGF-β (1,2,3) (1D11) (R&D Systems), LE135, retinoic acid (Tocris), or TGF-β R1 kinase inhibitor III (Calbiochem) in complete 1640 RPMI with L-gluatmaine media, supplemented with penicillin (1U/ml), streptomycin (100 μg/ml), 2.5 μM 2-ME and 10% fetal bovine serum (FBS) (Atlanta Biologicals).
+ Open protocol
+ Expand
2

Th22 Cell Adoptive Transfer for Allergy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naive CD4+ T cells from spleens of DO11.10 TCR transgenic mice were magnetically sorted using naive CD4+ T cell isolation kit, mouse (Miltenyi Biotec). Next, these cells were cultured in plate-bound antibodies against CD3 (145-2C11; 2 µg/ml; eBioscience) and soluble anti-CD28 (PV-1; 2 µg/ml; BioLegend), in the presence of IL-23 (40 ng/ml; R&D Systems), anti–IL-4 (11B11; 10 µg/ml; BioLegend), anti–IFN-γ (XMG1.2; 10 µg/ml; BioLegend), and anti–TGF-β1,2,3 (1D11; 10 µg/ml; R&D Systems) neutralizing antibodies to generate Th22 cells for 5 d. After extensive washings, 5 × 106 polarized T cells were adoptively transferred i.v. to naive WT or Il22−/− recipients, which were challenged the same day by EC sensitization with OVA (100 µg/100 µl PBS). For in vivo IL-17A neutralization, anti–IL-17A (17F3; 500 µg/ml; BioXCell) neutralizing antibodies or Control IgG1 (MOPC-21; 500 µg/ml; BioXCell) was i.p. injected 1 h before and 48 h after OVA challenge. 7 d later, the challenged skins were examined by histology and immunohistochemistry.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!